Advanced Oncotherapy
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2013 | 68.91K | -3.93M | -5711.72% |
|---|---|---|---|
| 2014 | 106.37K | -7.46M | -7015.85% |
| 2015 | 26.80K | -6.55M | -24456.22% |
| 2016 | 9.04K | -10.34M | -114390.93% |
| 2017 | 0 | -13.66M | |
| 2018 | 0 | -21.10M | |
| 2019 | 0 | -20.79M | |
| 2020 | 0 | -30.33M | |
| 2021 | 0 | -35.24M | |
| 2022 | 0 | 0 |
AVO.L Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 9.04K | 26.80K | 106.37K | 68.91K |
Cost of revenue | 0 | 2.33M | 2.33M | 2.02M | 1.90M | 365.47K | 345.37K | 33.75K | 202.67K | 155.95K |
Gross profit | 0 | -2.33M | -2.33M | -2.02M | -1.90M | -365.47K | -336.32K | -6.94K | -96.30K | -87.03K |
Operating exp. | ||||||||||
Research and development | 0 | 140 | 100K | 100K | 100K | 2.52M | 2.46K | 3.78K | 1.66K | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 0 | 23.73M | 20.26M | 20.65M | 19.89M | 14.49M | 13.08M | 7.61M | 5.55M | 2.03M |
Operating income | 0 | -23.73M | -20.26M | -20.65M | -21.79M | -14.49M | -13.08M | -8.50M | -6.45M | -3.17M |
Other income (expenses), net | 0 | -5.75M | -5.02M | -1.21M | -66.69K | -1.99M | -97.29K | -1.01M | -1.29M | -257.80K |
Income before tax | 0 | -29.49M | -25.29M | -21.87M | -21.86M | -16.48M | -13.18M | -8.62M | -6.33M | -3.43M |
Income tax expense | 0 | 5.75M | 5.03M | -1.08M | -759.41K | -2.82M | -2.81M | -2.78M | 2.43M | 1.55M |
Net income | 0 | -35.24M | -30.33M | -20.79M | -21.10M | -13.66M | -10.34M | -6.55M | -7.46M | -3.93M |
Earnings per share | ||||||||||
Basic EPS | 0 | -0.09 | -0.1 | -0.09 | -0.14 | -0.18 | -0.17 | -0.13 | -0.22 | -0.25 |
Diluted EPS | 0 | -0.09 | -0.1 | -0.09 | -0.14 | -0.18 | -0.17 | -0.13 | -0.22 | -0.25 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |